Showing results (541-550 of 1,393) with videos related to

Sort By:
Pageof 140
JCO Precision Oncology|September 16, 2025
Multicenter Phase II Study of Olaparib and the ATR Inhibitor Ceralasertib in Metastatic Castration-Resistant Prostate Cancer (TRAP)Irene Tsung, David C Smith, Elisabeth I Heath, et al.
JCO Precision Oncology|September 16, 2025
Association of Genetic Predisposition to Inflammation With Cancer-Related Cognitive Impairment and Fatigue in Women Who Received Chemotherapy for Nonmetastatic Breast CancerAyokunle S Olowofela, Paul L Auer, Michelle Janelsins, et al.
JCO Precision Oncology|August 6, 2025
Pan-Cancer Landscape of B- and T-Lymphocyte Attenuator: Implications for Potential Immunotherapy CombinationsDaisuke Nishizaki, Sharon Choi, Chinmayi Pandya, et al.
JCO Precision Oncology|September 26, 2025
Incorporating Continuous Mammographic Density Into the BOADICEA Breast Cancer Risk Prediction ModelLorenzo Ficorella, Mikael Eriksson, Kamila Czene, et al.
JCO Precision Oncology|August 7, 2025
Implementation of DPYD and UGT1A1 Testing in Patients With GI Cancer: A Prospective, Nonrandomized Clinical TrialSony Tuteja, Mari Angelica S Cayabyab, Glenda Hoffecker, et al.
JCO Precision Oncology|August 6, 2025
Clonal Hematopoiesis Prevalence Years Before a Thyroid Cancer Diagnosis: A Case-Control StudyPaloma L Cabral, Nikhila Aimalla, Kyle Shoger, et al.
JCO Precision Oncology|August 1, 2025
Mucin 16-Directed Therapy in Pediatric Sarcomas: Case Evidence of Ubamatamab Efficacy in Epithelioid Sarcoma and Its Implications for Other Sarcoma SubtypesDenise M Connolly, Gabriel Revon-Rivière, Rose Chami, et al.
JCO Precision Oncology|July 9, 2025
Transcriptomic Predictors of Survival for Palbociclib + Endocrine Therapy Versus Capecitabine in Aromatase Inhibitor-Resistant Breast Cancer From the GEICAM/2013-02 PEARL TrialYash N Agrawal, Aranzazu Fernández-Martínez, Miguel Gil-Gil, et al.
JCO Precision Oncology|July 10, 2025
Immune Checkpoint Inhibitors in Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor-Resistant Chemotherapy-Naïve Advanced Non-Small Cell Lung Cancer: A Meta-Analysis Based on Eight Randomized TrialsLetian Huang, Shuling Zhang, Li Sun, et al.
JCO Precision Oncology|July 23, 2025
Deep-Learning Model for Real-Time Prediction of Recurrence in Early-Stage Non-Small Cell Lung Cancer: A Multimodal Approach (RADAR CARE Study)Hyun Ae Jung, Daehwan Lee, Boram Park, et al.
Pageof 140